Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,749 | 3,906 | 3,524 | 11,367 | 9,837 |
| Marketable Securities | 2,110 | 3,175 | 4,141 | 3 | 420 |
| Other current assets | 320 | 0 | 0 | 66 | 0 |
| TOTAL | $7,388 | $7,112 | $7,681 | $11,572 | $10,402 |
| Non-Current Assets | |||||
| Intangibles | 217 | 241 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 59 | 65 | 71 | 88 |
| TOTAL | $217 | $300 | $65 | $71 | $88 |
| Total Assets | $7,605 | $7,412 | $7,746 | $11,643 | $10,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 578 | 1,584 | 704 | 364 | 418 |
| TOTAL | $650 | $1,656 | $776 | $436 | $490 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $650 | $722 | $794 | $866 | $938 |
| Total Liabilities | $1,300 | $2,378 | $1,569 | $1,302 | $1,428 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,167 | 4,484 | 2,844 | 3,159 | 98,672 |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -19,492 | -15,265 | -10,872 | -7,171 | -3,263 |
| Other shareholders' equity | 6 | 3 | -477 | 0 | 0 |
| TOTAL | $6,305 | $5,034 | $6,177 | $10,341 | $9,062 |
| Total Liabilities And Equity | $7,605 | $7,412 | $7,746 | $11,643 | $10,490 |